Brief: NRX Pharma Receives U.S. Patent Covering NRX-101
Feb 22 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS BUILDS ON ITS INTELLECTUAL PROPERTY
FOUNDATION FOR NEUROPSYCHIATRIC CONDITIONS - ADDS NEW U.S.
PATENT TO PORTFOLIO
* NRX PHARMACEUTICALS INC - RECEIVES NOTICE OF ISSUANCE OF
A U.S.
PATENT COVERING NRX-101
* NRX PHARMACEUTICALS INC - PATENT COVERS USE OF NRX-101 TO
TREAT
PATIENTS SUFFERING FROM DEPRESSION
Source text for Eikon: ID:nPn4k5DBka
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview